Fig. 2 | Scientific Reports

Fig. 2

From: Vitamin B17 alleviates Sorafenib-induced cardiotoxicity in Ehrlich Ascites Carcinoma mice via modulation of inflammatory and fibrotic pathways

Fig. 2

(A) Serum cardiac troponin (cTn) levels and (B) lactate dehydrogenase (LDH) activity in EAC-bearing mice treated with VB17 and/or Sorafenib (Sor). Groups included untreated EAC mice and mice receiving monotherapy or combination therapy via intraperitoneal (IP) or oral (O) routes. Data are presented as mean ± SEM (n = 6 per group). Statistical analysis was performed using one-way ANOVA followed by Tukey’s post hoc test. Significance is denoted as: ns (not significant), p ≤ 0.05 (*), p < 0.01 (**), p ≤ 0.001 (***). p ≤ 0.0001 (****).

Back to article page